Kamu erişimi zorunlu olan makaleler - Giada SebastianiDaha fazla bilgi edinin
Hiçbir yerde sunulmuyor: 22
Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
É Vuille-Lessard, B Lebouché, L Lennox, JP Routy, CT Costiniuk, ...
Aids 30 (17), 2635-2643, 2016
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
G Sebastiani, S Saeed, B Lebouche, A de Pokomandy, J Szabo, ...
Aids 34 (2), 237-244, 2020
Zorunlu olanlar: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
NASH in HIV
A Cervo, M Shengir, K Patel, G Sebastiani
Current HIV/AIDS Reports 17, 601-614, 2020
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Occult cirrhosis diagnosed by transient elastography is a frequent and under‐monitored clinical entity
T Chen, R Wong, P Wong, KC Rollet‐Kurhajec, R Alshaalan, ...
Liver International 35 (10), 2285-2293, 2015
Zorunlu olanlar: Fonds de recherche du Québec - Santé
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
XF Zeng, KA Varady, XD Wang, G Targher, CD Byrne, R Tayyem, ...
Metabolism 161, 156028, 2024
Zorunlu olanlar: National Health and Medical Research Council, Australia, Fonds de recherche …
Non-invasive diagnosis of nonalcoholic fatty liver disease in patients with type 2 diabetes
A Alhinai, K Patel, VA Fonseca, G Sebastiani
Journal of Diabetes and its Complications 35 (9), 107978, 2021
Zorunlu olanlar: Fonds de recherche du Québec - Santé
A stepwise algorithmic approach and external validation study for noninvasive prediction of advanced fibrosis in nonalcoholic fatty liver disease
HMK Kosick, A Keyrouz, O Adeyi, G Sebastiani, K Patel
Digestive Diseases and Sciences 66, 4046-4057, 2021
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Risk of liver-related events in metabolic dysfunction–associated steatohepatitis (MASH) patients with fibrosis: A comparative analysis of various risk stratification criteria
G Pennisi, M Enea, M Romero-Gomez, E Bugianesi, VWS Wong, ...
Hepatology 79 (4), 912-925, 2024
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Sarcopenic obesity at the crossroad of pathogenesis of cardiometabolic diseases
G Guaraldi, J Milic, G Sebastiani, P Raggi
Atherosclerosis 335, 84-86, 2021
Zorunlu olanlar: Fonds de recherche du Québec - Santé
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
H Zhang, G Targher, CD Byrne, SU Kim, VWS Wong, L Valenti, ...
Hepatology international 18 (4), 1178-1201, 2024
Zorunlu olanlar: National Institute of Health and Medical Research, France, Government of …
People living with HIV and NAFLD—A population left behind in the global effort for liver fibrosis screening?
G Sebastiani, J Milic, EA Tsochatzis, C Marzolini, M Betel, S Bhagani, ...
Hepatology 78 (5), E87-E88, 2023
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed/The Authors respond
G Sebastiani, M Deschenes
The Canadian Journal of Gastroenterology & Hepatology 29 (4), 219, 2015
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Fatty liver in children with HIV: a clinical iceberg?
G Sebastiani, G Sebastiani
AIDS 36 (10), 1469-1471, 2022
Zorunlu olanlar: Fonds de recherche du Québec - Santé, Government of Spain
Global, regional, and national burden of primary liver cancer attributable to metabolic risks: an analysis of the Global Burden of Disease Study 1990-2021
C Wu, G Targher, CD Byrne, Y Mao, TT Cheung, Y Yilmaz, L Valenti, ...
Official journal of the American College of Gastroenterology| ACG, 10.14309, 2022
Zorunlu olanlar: National Natural Science Foundation of China
Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors and the Prevention of Cirrhosis Among Patients With Type 2 Diabetes
R Pradhan, H Yin, S Lu, G Sebastiani, O Yu, S Suissa, L Azoulay
Diabetes Care, dc241903, 2025
Zorunlu olanlar: Fonds de recherche du Québec - Santé
A259 Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated With Multi-Organ Comorbidities And Fibrosis Progression In Patients With Inflammatory Bowel Disease …
D Kablawi, S Sasson, F Aljohani, CS Palumbo, A Bitton, W Afif, ...
Journal of the Canadian Association of Gastroenterology 7, 208-209, 2024
Zorunlu olanlar: Canadian Institutes of Health Research
Increased serum fibroblast growth factor 23 predicts mortality in people with HIV/HCV coinfection
M Shengir, C Fillebeen, J Wagner, AV Ramanakumar, M Kaouache, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 94 (3), 273-279, 2023
Zorunlu olanlar: Fonds de recherche du Québec - Santé
The quest for the ideal NASH biomarker
G Sebastiani
The Lancet Gastroenterology & Hepatology 8 (8), 685-687, 2023
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Nonalcoholic fatty liver disease in human immunodeficiency virus: the (Not So) new kid on the block?
T Krahn, G Sebastiani
Clinical Infectious Diseases 71 (1), 243-244, 2020
Zorunlu olanlar: US National Institutes of Health, Fonds de recherche du Québec - Santé
Integrating behavioral interventions into a holistic approach to metabolic dysfunction-associated steatotic liver disease
R Righetti, F Cinque, MT Volpe, G Sebastiani
Expert Review of Gastroenterology & Hepatology 18 (7), 303-313, 2024
Zorunlu olanlar: Fonds de recherche du Québec - Santé
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir